HiPower

Guangzhou Hipower Pharmaceutical R&D Co., Ltd. (hereinafter referred to as "HiPower") was established in October 2009, located at 2nd Floor, Tianhai Business Building, No. 3 Tianhai Street, Haizhu District, Guangzhou. The current office area is about 1,200 square meters, with a registered capital of 3.18 million yuan. It is the only local CRO company in China that has passed the international ISO 9001:2008 quality management system certification and the first domestic CRO company to undertake stem cell clinical trials. In 2012, it obtained 3 invention patents for pharmaceuticals, and in 2015, it was recognized as a High-tech Enterprise.
HiPower primarily provides technical outsourcing services for clinical trials of pharmaceutical products, including clinical trials of new products and post-marketing re-evaluation clinical research for traditional Chinese medicine, chemical drugs, biological products, health foods, medical devices, and diagnostic reagents, as well as human pharmacokinetics and bioequivalence (generic drug consistency evaluation) technical outsourcing services. To date, it has undertaken more than 20 new drug clinical trial projects and more than 20 post-marketing re-evaluation projects, with rich project experience in obstetrics and gynecology, pediatrics, endocrinology, infectious diseases, respiratory medicine, orthopedics, gastroenterology, psychiatry, neurology, oncology, ophthalmology, and other fields.
HiPower currently has 17 resident offices across the country, distributed in Nanning, Liuzhou, Haikou, Zhengzhou, Shenzhen, Fuzhou, Wuhan, Changsha, Jinan, Yantai, Shanghai, Nanjing, Beijing, Shenyang, Changchun, Chengdu, Shanghai, Tianjin, etc., ensuring efficient operation and goal achievement of client projects.
Through years of sound operation, HiPower has formed an efficient scientific system with distinctive features, positioning itself on precise design of clinical trial protocols and striving for refined management of clinical trials.